Pazdur’s exit at FDA has biotech afraid of agency ‘tipping point’

Rick Pazdur, the head of the FDA's drug office, is expected to leave the agency less than a month after stepping into the role. His exit comes after he was personally lobbied by Commissioner Marty ...